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Abstract
Selected reaction monitoring mass spectrometry has been combined with the use of an isotopically labelled
synthetic protein, made up of proteotypic tryptic peptides selected from parasite proteins of interest. This allows,
for the first time, absolute quantification of proteins from Plasmodium falciparum. This methodology is
demonstrated to be of sufficient sensitivity to quantify, even within whole cell extracts, proteins of low abundance
from the folate pathway as well as more abundant “housekeeping” proteins.
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Background
Human malaria caused by Plasmodium falciparum is a
major global health burden, killing around 1 million people
every year [1]. Africa bears the greatest proportion of this
burden, with over three-quarters of deaths occurring in
African children, accounting for nearly a fifth of all child
deaths in sub-Saharan Africa [2]. With the sequencing of
the genome [3], as well as great advances in mass spectro-
metry (MS), characterization of the P. falciparum pro-
teome is now technically possible. Information obtained
using these techniques should be valuable in informing our
future understanding of parasite/human interactions, dis-
ease progression and the selection of novel drug targets.
One important recent advance in MS is the develop-
ment of so-called selected reaction monitoring (SRM).
This is an analysis method used in triple quadrupole mass
spectrometers. The first quadrupole acts as a mass filter,
allowing through only ions of selected mass/charge ratios
before they are fragmented, using the second quadrupole
as a collision cell. The final quadrupole then acts as a
mass filter of resulting fragment ions in a similar way to
the first quadrupole, allowing through only fragment ions
of a particular, selected mass [4]. Since different peptides
of the same mass would be expected to show different
fragmentation patterns, this method provides an extra
degree of certainty of protein identification compared to
MS of the peptides alone.
Further to these advances, recent work from this labora-
tory [5] has demonstrated that a form of ‘soft’ extraction
of erythrocytic-stage P. falciparum parasites can resolve
the issue of haemoglobin-derived products, which pre-
viously caused great hindrance in downstream methods of
protein analysis. In addition, this work demonstrated the
utility of the OFFGEL™ (Agilent, UK) isoelectric fractio-
nation system in separating whole P. falciparum proteins,
rather than tryptic peptides, according to their pI. This
fractionation is vitally important in the identification of
proteins of low abundance, such as those of the folate and
many other metabolic pathways, due to the complexity of
the proteome. It is estimated that even in the most com-
prehensive proteomic studies of the P. falciparum life-
cycle to date, only ~46% of the predicted gene products
were detected [6,7].
As well as identifying proteins of interest by fractiona-
tion followed by mass spectrometry, quantification of
these proteins is also highly valuable in understanding the
dynamics of biological systems. It has been shown a num-
ber of times that the expression of a particular gene as
measured by mRNA quantification does not necessarily
correlate with the level of protein within the cell [8-11].
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contains many unstructured proteins that can experience
rapid degradation at both mRNA and protein levels
[12,13]. In addition, the nature and degree of post-transla-
tional modifications, which can determine a number of
protein properties including function, localization and
activity, can only be analysed at the protein level.
Quantitative proteomics of the P. falciparum parasite is
a field still in its infancy. In 2004, relative quantification
was performed in this laboratory using a SILAC (stable-
isotope labelling of amino acids in cell culture) -based
method [11]. While a significant step forward for plasmo-
dial proteomics, this study necessarily focused on proteins
of high abundance to establish proof of principle. Since
then, other significant studies have been undertaken to
assess plasmodial proteins in a quantitative manner
[14,15], but again, these studies determined only relative
quantification.
In order to truly understand a biological system, we must
aspire to absolute quantification of proteins across their
entire dynamic range. By doing this, data from different
studies and different laboratories can be more easily com-
pared and proteomic, transcriptomic and metabolomic
data can be more meaningfully correlated. One potential
method for absolute protein quantification is the use of a
heterologously expressed so-called QconCAT protein [16].
In this method, proteotypic tryptic peptides from pro-
teins of interest, ‘Q-peptides’, are chosen. A number of
these peptides are then expressed together from an artifi-
cial gene to produce a concatenated protein containing
many different Q-peptides. Thus, when the QconCAT
protein is digested using trypsin, peptides representing a
number of proteins of interest are produced in equal molar
amounts. If such QconCAT proteins are expressed, from
Escherichia coli, in a labelled form using stable-isotope
labelling, they can then be introduced, in a known amount,
into biological samples prior to tryptic digestion and mass
spectrometry. The resulting ‘heavy’ peaks on mass spectra,
derived from the Q-peptides can be compared with the
corresponding ‘light’ peaks, obtained concurrently from
the native peptides, allowing accurate, absolute quantifica-
tion. Producing a labelled QconCAT, rather than a labelled
form of an entire native protein, allows several proteins to
be efficiently quantified in the same experiment.
Here a QconCAT-based method, combined with SRM
mass spectrometry, is described for the absolute quantifi-
cation of proteins of low abundance in erythrocytic-stage
P. falciparum.
Methods
Plasmodium falciparum culture
Plasmodium falciparum K1 parasites were grown in
washed O+ erythrocytes in RPMI 1640 medium
(Invitrogen, UK) as previously described [11,17]. The
medium was supplemented with 0.5% bovine serum albu-
min, 5 μg.ml
-1 hypoxanthine and 50 μg.ml
-1 gentamicin
sulphate (all Sigma Aldrich).
Extraction of parasites
Plasmodium falciparum parasites were freed from infected
erythrocytes by lysis in 0.05% saponin in phosphate-buf-
fered saline (PBS) for 5 min. at 4°C. This suspension was
subsequently centrifuged at 800g for 5 min. at 4°C. The
resulting parasite pellets were washed in ice-cold PBS and
spun at 1,000g for 5 min. This washing process was
repeated at least twice more, until contaminating blood
cell lysis products were no longer apparent in the PBS.
The subsequent pellet was weighed and, if not being used
immediately, snap-frozen in liquid nitrogen before storage
at -80°C.
Extraction of Plasmodium falciparum proteins
Proteins were extracted from P. falciparum samples using
the freeze-thaw method previously described [5]. For every
100 μg of parasite pellet, 2.5 ml of de-ionized water and
5 μl of protease inhibitor cocktail (Sigma Protease Inhibi-
tor Cocktail, P8340) was added and the pellet re-sus-
pended. This suspension was frozen in liquid nitrogen for
5 min., thawed in a 37°C water bath and vortexed for
30 sec. at room temperature. This freeze-thaw cycle was
subsequently repeated four times to ensure maximum pro-
tein extraction. The insoluble material was wholly
removed by centrifugation three times at 16,000g for
20 min. at 4°C. The soluble proteins thus extracted were
precipitated by the addition of five volumes of acetone to
the solution followed by incubation at -20°C overnight.
The resulting suspension was subsequently centrifuged at
12,000g for 20 min. at 4°C and the protein pellet air-dried.
Design of PfQconCAT1
Twelve P. falciparum proteins were chosen to be repre-
sented in the PfQconCAT1 protein. These included six
enzymes of folate metabolism: GTP cyclohydrolase I
(GTPCH), pyruvoyltetrahydropterin synthase III (PTPS),
hydroxymethyldihydropterin pyrophosphokinase-dihydrop-
teroate synthase (HPPK-DHPS), dihydrofolate synthase-
folylpolyglutamate synthase (DHFS-FPGS), dihydrofolate
reductase-thymidylate synthase (DHFR-TS) and serine
hydroxymethyltransferase (SHMT). All of these proteins
are known to be of a low abundance [5,18]. In order to
represent some proteins of higher abundance and thus
provide a context for the abundance figures sought, the fol-
lowing proteins were also represented: adenosine deami-
nase, disulphide isomerase, eukaryotic initiation factor 5a
(eIF5a), lactate dehydrogenase (LDH), plasmepsin I and
pyruvate kinase. Each protein was represented by four
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tides were also included (see Additional file 1 - Annotated
amino acid sequence of PfQconCAT1).
For those folate pathway proteins identified previously
by mass spectrometry in our laboratory (PTPS, HPPK-
DHPS, DHFR-TS and SHMT), peptides were chosen
which had previously been seen in the mass spectra [5].
For those proteins in which more than four different pep-
tides had been seen, the four seen with highest intensity
were chosen. For all other proteins, theoretical peptides
were chosen using Peptide Predictor Version 2 software.
This is a locally written derivative of the widely available
Peptide Sieve software (Seattle Proteome Center). The
software allows screening of peptides in proteins for high
‘flyability’ and low probability of missed cleavages in tryp-
sin digestion (for example, ensuring that an acidic amino-
acid residue is not present two places after a lysine or
arginine residue). This program was first run using those
proteins already identified in mass spectra. The predic-
tions made by the software were found to be highly con-
cordant with the visibility of peptides in experimental
results.
In the QconCAT protein, no two peptides representing
the same protein were placed consecutively. This was to
ensure that any missed cleavages did not eliminate the
ability for quantification of two peptides from the same
protein. A process of trial and error was then used placing
the 74 peptides in various configurations and assessing
with Peptide Predictor to ensure that missed tryptic clea-
vages remained a low probability. A sacrificial N-terminus
and His-tagged C-terminus (to facilitate purification) were
then added and the sequence was sent to PolyQuant
(http://www.polyquant.com) for codon optimization and
gene synthesis. The amino-acid sequence is shown in
annotated form (Additional file 1 - Annotated amino acid
sequence of PfQconCAT1).
Synthesis of labelled PfQconCAT1 protein
Rosetta™ 2 (DE3) pLysS cells were transformed with the
sequence-verified, artificial PFQconCAT1 gene received
from PolyQuant in the pET21 vector. These cells were
grown overnight on LB agar and used to inoculate 500 ml
of PA-5052 medium [19] supplemented with both
13C-
labelled arginine and
13C-labelled lysine (0.2 mg.ml
-1
each). PA-5052 is made as follows: 50 mM Na2HPO4,
50 mM KH2PO4,2 5m M( N H 4)2SO4,0 . 5 %( v / v )g l y c e r o l ,
0.05% (w/v) glucose, 0.2% (w/v) a-lactose monohydrate, 2
mM MgSO4,5 0m MF e C l 3,2 0μMC a C l 2,1 0μMM n C l 2,
10 μMZ n S O 4,2μMC o C l 2,2μMC u C l 2,2μMN i C l 2,
2 μMN a 2MoO4,2μMN a 2SeO3,2μMH 3BO3 and
0.2 mg.ml
-1 each of the following amino acids: alanine,
aspartate, glutamine, glycine, isoleucine, leucine, methio-
nine, proline, serine, threonine, tryptophan, valine, pheny-
lalanine, monosodium glutamate, asparagine monohydrate
and histidine monochloride. The cells were then grown in
this auto-induction medium over two nights at 37°C with
agitation until the OD600 plateaued (usually an OD600 of
between 6 and 12). The cells were then harvested by cen-
trifugation for 20 min. at 4,000g at 4°C.
These cells were subsequently processed as described
previously [20]. The cells were lysed using Bugbuster
(Novagen) according to the manufacturer’sg u i d e l i n e s .
The resulting suspension was centrifuged at 16,000g for
20 min. at 4°C and the supernatant discarded. The pellet
was re-suspended in the same amount of Bugbuster again
by Pasteur pipetting. Lysozyme (250 ml of 10 mg.ml
-1 in
Bugbuster) was added and mixed by gentle vortexing. This
was incubated at room temperature for 5 min. followed by
centrifuging at 15,000g f o r1 5m i n .a t4 ° C .T h er e s u l t i n g
supernatant was discarded. This pellet was re-suspended
in 20 ml of a 1/10 dilution of Bugbuster in de-ionized
water then centrifuged again at 15,000g for 15 min. at 4°C.
This washing in 1/10 Bugbuster was repeated twice more
to produce a pellet of washed inclusion bodies.
The inclusion bodies were re-suspended in 20 ml of col-
umn buffer (20 mM Na2HPO4/NaH2PO4 pH7.4, 500 mM
NaCl, 10 mM imidazole, 6 M guanidinium chloride [all
S i g m aA l d r i c h ] )a n dw e r es u b s e q u e n t l yc e n t r i f u g e da t
8,000 rpm for 5 min. at room temperature. The superna-
tant was transferred to a fresh tube and the pellet dis-
carded. A 1 ml HiTrap Chelating HP column (GE
Healthcare) was equilibrated with column buffer using an
AKTA purification system. The previously prepared crude
extract was then applied to the column at a flow rate of
0.25 ml.min.
-1 and the column was washed with wash buf-
fer (20 mM Na2HPO4/NaH2PO4 pH7.4, 500 mM NaCl,
20 mM imidazole, 6 M guanidinium chloride) until no
protein could be seen eluting from the column on the UV
absorbance output. The bound protein was then eluted
from the column by switching from wash buffer to elution
buffer (20 mM Na2HPO4/NaH2PO4 pH7.4, 500 mM
NaCl, 500 mM imidazole, 6 M guanidinium chloride) on a
20 min. linear gradient. The resulting solution was dia-
l y s e di n t o6Mu r e ao v e r n i g h t .D i a l y s i n gi n t ol o w e rc o n -
centrations was found to result in precipitation of the
protein, which would subsequently prove difficult to re-
solubilize. Quantification of the protein was performed
using a 2D Quant kit (GE Healthcare).
Selected reaction monitoring mass spectrometry analysis
Acetone-precipitated protein obtained from P. falciparum
samples was trypsin-digested using an Amicon Ultra
0.5 ml 10 kDa molecular weight cut-off centrifugal filter
unit (Millipore). The dried protein sample was first taken
up in 15.5 μl digestion buffer (50 mM NH4HCO3,2 0m M
CaCl2, 2 M Urea) and applied to the upper chamber of an
Amicon filter. An appropriate, known amount of labelled
PfQconCAT1 protein was added (1 pmol per 100 μg
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the whole incubated for 20 min. at room temperature.
Subsequently, 2 μl of 30 mM iodoacetamide was added
and incubated for a further 20 min. at room temperature.
A further 200 μl of digestion buffer was then added and
the column was spun at 14,000g for 15 min. The filtrate
was then discarded and the filter chamber transferred to a
fresh tube. Proteomics grade trypsin (0.1 mg.ml
-1,S i g m a
Aldrich) in 50 mM NH4HCO3 was then added to give
1 μg trypsin for every 50 μg protein to be digested and the
whole was incubated overnight at 37°C. Formic acid (1 μl)
was added to stop the reaction followed by 200 μlo f
50 mM NH4HCO3. The column was centrifuged at
14,000g for 15 min. and the filter was discarded. The
filtrate was then dried in a vacuum centrifuge and re-sus-
pended in 10% acetonitrile, 0.1% formic acid for analysis
by mass spectrometry.
This analyte was loaded onto a Symmetry
® C18 HPLC
trapping column of 20 mm length and an internal dia-
meter (ID) of 180 μm (Waters) coupled to a BEH130 C18
HPLC analytical column of 15 cm length and an ID of
75 μm (Waters nanoACQUITY™ UPLC). The peptides
were eluted from these columns using a 3-40% gradient of
100% acetonitrile with water (both containing 0.1% formic
acid) at a flow rate of 300nl.min
-1.T h ep e p t i d e sw e r e
eluted into a Xevo TQMS (Waters) mass spectrometer
(ionization through electrospray ionization and mass ana-
lysis through tandem quadrupoles) using an SRM transi-
tion list (see Additional file 2 - SRM Transition List). Data
were acquired using MassLynx software (Waters).
Tandem mass spectrometry analysis
Trypsin-digested analyte was loaded onto a Symmetry
®
C18 HPLC trapping column of 20 mm length and an
internal diameter (ID) of 180 μm (Waters) coupled to a
BEH130 C18 HPLC analytical column of 15 cm length
and an ID of 75 μm (Waters nanoACQUITY™ UPLC).
The peptides were eluted from these columns using a 3-
40% gradient of 100% acetonitrile with water (both con-
taining 0.1% formic acid) at a flow rate of 300nl.min
-1.T h e
peptides were eluted into a Synapt G1 High Definition
mass spectrometer (Waters; ionization through electro-
spray and mass analysis through quadrupole time of flight)
run in MS
E mode. Data were acquired and analysed using
MassLynx (v4.1) and Protein Lynx Global Server (v2,4)
software packages respectively (Waters).
Results
Development of PfQconCAT1 SRM transition list
Initially, an SRM transition list was produced for the
PfQconCAT1 protein using Pinpoint software (Thermo
Finnigan) to predict what fragment ions might be seen
from the second round of MS (see Additional file 2 - SRM
Transition List). This analysis also recognized the value of
choosing singly charged fragment ions whose m/z was
greater than that of their doubly charged parent ions, thus
helping to minimize background intensity that might be
generated from the latter during the SRM analyses. How-
ever, to be sure that useful fragment ions would indeed be
produced experimentally, purified heterologously
expressed PfQconCAT1 was trypsin digested and run in
MS
E mode on a Synapt G1 QToF mass spectrometer. The
list of precursor and fragment ions seen (see Additional
file 3 - Precursor and fragment ions found through trypsin
digestion and Synapt QToF mass spectrometry of hetero-
logously expressed
13C-labelled PfQconCAT1), which
includes those derived from all of the targeted proteins
other than plasmepsin I, is significantly different to that
prepared using the predictive software (see Additional file
2 - SRM Transition List). Thus, approximately 77% of pre-
dicted fragment ions were not seen experimentally and
37% of ions seen experimentally were not predicted. This
discordance between predictions of which theoretical pep-
tides might be best chosen as proteotypic, particularly
with respect to their detectioni nt h em a s ss p e c t r o m e t e r
(selection of characteristic transitions) is notable. It illus-
trates the value, for future studies, of taking every effort to
select peptides/transitions that have previously been
experimentally demonstrated.
Quantification of Plasmodium falciparum proteins
Trypsin-digested P. falciparum protein (2 μg) was loaded
onto the Xevo TQ mass spectrometer and analysed using
SRM as described above. Results from QconCAT-based
quantification of proteins from two unsynchronized
P. falciparum cultures are shown in Table 1.
In order for quantification to be performed, both
labelled and unlabelled forms of the peptides must be
seen in mass spectra of the samples. This was the case
for three of the peptides in both experiments (represent-
ing DHFR-TS, eIF5a and SHMT) and for two additional
peptides in one of the experiments (representing adeno-
sine deaminase and disulphide isomerase). Extracted ion
chromatograms of three transitions from both labelled
and unlabelled forms of a peptide chosen as diagnostic
for SHMT (SHMT-4) are shown in Figure 1. Additional
file 4 - Extracted ion chromatograms from experimen-
tally observed peptides - shows all of the transitions
observed in the two independent experiments from
which the data presented in Table 1 were derived. The
fact that some peptides were seen in one experiment and
not in the other may reflect differences in ion suppres-
sion effects in different complex mixtures of peptides.
For those peptides seen in both experiments, a high
degree of reproducibility was seen with similar abun-
dance figures obtained for the same peptides in each
experiment (standard error varied between 4.0% and
6.7% of the average).
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Peptide Fragment Ion Type Calculated Native Level (Culture 1) Peptide Average Calculated Native Level (Culture 2) Peptide Average Average Between Samples
Adenosine Deaminase-1 y4 5.96 6.53 (0.23) - - -
y5 6.83 -
y6 6.79 -
Disulphide Isomerase-1 y5 9.54 16.47 (2.83) - - -
y6 20.11 -
y7 19.76 -
DHFR-TS-4 y7 0.68 0.31 (0.15) 0.24 0.68 (0.20) 0.50 (0.02)
y8 0.05 1.09
y10 0.21 0.72
eIF5a-3 y6 18.64 19.05 (1.90) 20.33 22.98 (2.13) 21.02 (1.39)
y8 15.23 28.20
y9 23.27 20.41
SHMT-4 y5 0.48 0.87 (0.31) 0.69 0.99 (0.29) 0.93 (0.04)
y6 0.49 1.69
y7 1.63 0.58
All figures are pmol per 100 μgo fP. falciparum protein and numbers in brackets represent standard errors. Adenosine Deaminase-1 and Disulphide Isomerase-1 were only detected in experiment 1.
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Figure 1 Extracted ion chromatograms of transitions derived from peptide SHMT-4. The ordinate represents the peak intensity (normalised
to 100%) and the abscissa the time within the elution gradient (minutes) that this intensity was detected. Panel A, transitions corresponding to
the labelled version of this peptide; Panel B, transitions corresponding to the unlabelled version of this peptide. The relative area under each of
the traces and the known amount of the standard (labelled) peptide added were used to calculate the amount of the unlabelled peptide and
thus the amount of the equivalent protein present in the sample analyzed.
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reflect what would be expected, with enzymes of the
folate pathway of substantially lower abundance than
the other enzymes. Furthermore, the two enzymes iden-
tified from the folate pathway are the two hypothesized
to be the two most abundant within this pathway based
on previous transcriptomic data [11]. In that study, the
SHMT transcript was also found to be more abundant
than that of DHFR-TS, a result also reflected in these
proteomic results. Another notable outcome from these
experiments is that in using a mass spectrometric
method as sensitive as SRM, proteins of very low abun-
dance can be seen without any fractionation of such a
complex proteome. Fractionation using methods such as
OFFGEL™ isoelectric fractionation have recently been
demonstrated to have the potential to mine deep into
the proteome, with four of the six folate enzymes being
identified using this method [5]. Using the SRM method
described in this paper in combination with OFFGEL™,
a fifth folate enzyme (GTPCH) has also been identified
(data not shown) showing the potential of this combined
approach to mine and quantify a large portion of the P.
falciparum proteome.
Conclusions
Combining the use of a heavy-labelled, custom-designed
QconCAT protein with SRM mass spectrometry has
allowed the absolute quantification of even low abundance
proteins from the folate metabolic pathway within unfrac-
tionated cell extracts. This method can easily be targeted
to any plasmodial protein, for the first time offering a
direct route to absolute quantification of malarial proteins.
F u r t h e r m o r e ,w i t ht h ea b i l i t yt or e p r e s e n tad o z e no r
more proteins of interest in one labelled artificial protein,
there is great potential for this approach to provide a rela-
tively high-throughput application to absolutely quantify
plasmodial proteomics. Such quantification will be a prere-
quisite for successful application of systems biology tech-
niques to the in-depth analysis of parasite biochemistry.
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